Adjuvant Global Health Technology Fund, L.P.

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 80% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Adjuvant Global Health Technology Fund, L.P.'s trades of AN2 Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
86.63
Quantity 13,350 -39.9%
Value US$2,224,598
Transaction date
Proposed sale
Price
392.79
Quantity 8,991
Value US$3,993,708
Transaction date
Planned sale
Price
16.15
Quantity 288 -0.1%
Value US$4,650
Transaction date
Planned sale
Price
16.15
Quantity 1,522 -0.1%
Value US$24,574
Transaction date
Planned sale
Price
16.07
Quantity 4,770 -0.2%
Value US$76,654
Transaction date
Planned sale
Price
16.28
Quantity 15,764 -3.8%
Value US$256,638
Transaction date
Planned sale
Price
16.28
Quantity 83,337 -3.8%
Value US$1,356,726
Transaction date
Planned sale
Price
16.11
Quantity 1,356 -0.3%
Value US$21,845
Transaction date
Planned sale
Price
16.11
Quantity 7,160 -0.3%
Value US$115,348
Transaction date
Planned sale
Price
16.07
Quantity 134 -0.0%
Value US$2,153
Transaction date
Planned sale
Price
16.07
Quantity 707 -0.0%
Value US$11,361
Transaction date
Planned sale
Price
16.00
Quantity 336 -0.0%
Value US$5,376
Transaction date
Planned sale
Price
16.05
Quantity 2,841 -0.1%
Value US$45,598
Transaction date
Planned sale
Price
16.02
Quantity 3,164 -0.1%
Value US$50,687
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-18 2024-01-16
S Sale
45,948 +46.5%
421.64
US$267,275 		45,948 +46.5% 421.64 US$267,275
2024-01-18 2024-01-16
S Sale
13,350 -39.9%
86.63
US$2,224,598 		13,350 -39.9% 86.63 US$2,224,598
2024-01-16 2024-01-16
PrS Proposed sale
8,991
392.79
US$3,993,708 		8,991 392.79 US$3,993,708
2023-11-16 2023-11-14
PlS Planned sale
288 -0.1%
16.15
US$4,650 		288 -0.1% 16.15 US$4,650
2023-11-16 2023-11-14
PlS Planned sale
1,522 -0.1%
16.15
US$24,574 		1,522 -0.1% 16.15 US$24,574
2023-10-03 2023-10-02
PlS Planned sale
902 -0.2%
16.07
US$14,495 		902 -0.2% 16.07 US$14,495
2023-10-03 2023-10-02
PlS Planned sale
4,770 -0.2%
16.07
US$76,654 		4,770 -0.2% 16.07 US$76,654
2023-10-03 2023-09-29
PlS Planned sale
15,764 -3.8%
16.28
US$256,638 		15,764 -3.8% 16.28 US$256,638
2023-10-03 2023-09-29
PlS Planned sale
83,337 -3.8%
16.28
US$1,356,726 		83,337 -3.8% 16.28 US$1,356,726
2023-09-29 2023-09-28
PlS Planned sale
1,356 -0.3%
16.11
US$21,845 		1,356 -0.3% 16.11 US$21,845
2023-09-29 2023-09-28
PlS Planned sale
7,160 -0.3%
16.11
US$115,348 		7,160 -0.3% 16.11 US$115,348
2023-09-29 2023-09-27
PlS Planned sale
134 -0.0%
16.07
US$2,153 		134 -0.0% 16.07 US$2,153
2023-09-29 2023-09-27
PlS Planned sale
707 -0.0%
16.07
US$11,361 		707 -0.0% 16.07 US$11,361
2023-09-15 2023-09-13
PlS Planned sale
64 -0.0%
16.00
US$1,024 		64 -0.0% 16.00 US$1,024
2023-09-15 2023-09-13
PlS Planned sale
336 -0.0%
16.00
US$5,376 		336 -0.0% 16.00 US$5,376
2023-09-08 2023-09-07
PlS Planned sale
537 -0.1%
16.05
US$8,619 		537 -0.1% 16.05 US$8,619
2023-09-08 2023-09-07
PlS Planned sale
2,841 -0.1%
16.05
US$45,598 		2,841 -0.1% 16.05 US$45,598
2023-09-08 2023-09-06
PlS Planned sale
598 -0.1%
16.02
US$9,580 		598 -0.1% 16.02 US$9,580
2023-09-08 2023-09-06
PlS Planned sale
3,164 -0.1%
16.02
US$50,687 		3,164 -0.1% 16.02 US$50,687
2023-08-25 2023-08-23
S Sale
64 -0.0%
16.00
US$1,024 		64 -0.0% 16.00 US$1,024
2023-08-25 2023-08-23
S Sale
336 -0.0%
16.00
US$5,376 		336 -0.0% 16.00 US$5,376